Nippon Kayaku Overview
- Year Founded
-
1916
- Status
-
Public
- Employees
-
6,588
- Stock Symbol
-
4272
- Investments
-
15
- Share Price
-
$11.13
- (As of Friday Closing)
Nippon Kayaku General Information
Description
Nippon Kayaku Co Ltd manufactures and sells a variety of chemicals. The firm organizes itself into three segments based on product type. Mobility & Imaging Business Area, Fine Chemicals Business Area, and Life Sciences Business Area.
Contact Information
Website
www.nipponkayaku.co.jpCorporate Office
- Meiji Yasuda Seimei Building 19th and 20th Floors
- 1-1, Marunouchi 2-chome, Chiyoda-ku
- Tokyo, 100-0005
- Japan
Corporate Office
- Meiji Yasuda Seimei Building 19th and 20th Floors
- 1-1, Marunouchi 2-chome, Chiyoda-ku
- Tokyo, 100-0005
- Japan
Nippon Kayaku Stock Performance
As of 20-Nov-2026, Nippon Kayaku’s stock price is $11.13. Its current market cap is $1.6B with 143M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $11.13 | $11.64 | $9.60 - $13.84 | $1.6B | 143M | 616K | $1.25 |
Nippon Kayaku Financials Summary
As of 30-Sep-2026, Nippon Kayaku has a trailing 12-month revenue of $1.67B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 2,037,066 | 1,635,136 | 1,397,960 | 1,304,893 |
| Revenue | 1,666,480 | 1,604,585 | 1,459,585 | 1,396,576 |
| EBITDA | 340,162 | 326,767 | 232,147 | 144,585 |
| Net Income | 184,390 | 163,483 | 114,808 | 28,466 |
| Total Assets | 2,671,571 | 2,494,314 | 2,497,341 | 2,399,557 |
| Total Debt | 407,068 | 307,673 | 281,311 | 207,797 |
Nippon Kayaku Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Nippon Kayaku Patents
Nippon Kayaku Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2026142576-A | Curable resin composition and its cured product | Pending | 06-Mar-2026 | ||
| JP-2026142541-A | Curable resin composition and its cured product | Pending | 28-Jan-2026 | ||
| JP-2026142542-A | Curable resin composition and its cured product | Pending | 28-Jan-2026 | ||
| JP-2026142515-A | Curable resin composition and its cured product | Pending | 14-Nov-2025 | ||
| JP-2026142516-A | Curable resin composition and its cured product | Pending | 14-Nov-2025 |
Nippon Kayaku Signals
Nippon Kayaku Investments & Acquisitions (15)
Nippon Kayaku’s most recent deal was a Merger/Acquisition with Fuji Pharmaceutical (Toyama No. 2 Plant Injectable Drug Business). The deal was made on 01-Oct-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Fuji Pharmaceutical (Toyama No. 2 Plant Injectable Drug Business) | 01-Oct-2026 | Merger/Acquisition | Pharmaceuticals | ||
| Sanko Chemical Industry | 07-Sep-2026 | Secondary Transaction - Private | Agricultural Chemicals | ||
| Sanko Chemical Industry | 07-Sep-2026 | Merger/Acquisition | Agricultural Chemicals | ||
| Sanko Chemical Industry | 01-Jan-2026 | Corporate | Agricultural Chemicals | ||
| In-licensing Pharmaceutical Products (CBC / Formiica Pharmaceuticals / Nippon Kayaku) | 08-Aug-2025 | Joint Venture | Other Pharmaceuticals and Biotechnology |
Nippon Kayaku ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
26.07 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Chemicals
Industry
of 503
Rank
Percentile
Specialty Chemicals
Subindustry
of 165
Rank
Percentile
Nippon Kayaku Exits (3)
Nippon Kayaku’s most recent exit was on 01-Dec-2019 from KUREi. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| KUREi | 01-Dec-2019 | Completed |
|
||
| ILFORD Imaging Switzerland | 01-Aug-2011 | Completed |
|
||
| GlycoMark | 17-Jul-2008 | Joint Venture | Completed |
|
Nippon Kayaku Affiliates
Subsidiaries (7)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Aero Systems West | San Martin, CA | 2015 | |
| Teikoku Taping System | Tokai, Japan | 1995 | |
| Kayaku Advanced Materials | Westborough, MA | 1992 | |
| Polatechno Company | Joetsu, Japan | 1991 | |
| Kayaku Nouryon Co. | Tokyo, Japan | 1970 |
Nippon Kayaku FAQs
-
When was Nippon Kayaku founded?
Nippon Kayaku was founded in 1916.
-
Where is Nippon Kayaku headquartered?
Nippon Kayaku is headquartered in Tokyo, Japan.
-
What is the size of Nippon Kayaku?
Nippon Kayaku has 6,588 total employees.
-
What industry is Nippon Kayaku in?
Nippon Kayaku’s primary industry is Specialty Chemicals.
-
Is Nippon Kayaku a private or public company?
Nippon Kayaku is a Public company.
-
What is Nippon Kayaku’s stock symbol?
The ticker symbol for Nippon Kayaku is 4272.
-
What is the current stock price of Nippon Kayaku?
As of 20-Nov-2026 the stock price of Nippon Kayaku is $11.13.
-
What is the current market cap of Nippon Kayaku?
The current market capitalization of Nippon Kayaku is $1.6B.
-
What is Nippon Kayaku’s current revenue?
The trailing twelve month revenue for Nippon Kayaku is $1.67B.
-
What is Nippon Kayaku’s annual earnings per share (EPS)?
Nippon Kayaku’s EPS for 12 months was $1.25.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process